Schedule 13G ownership disclosure
LB Pharmaceuticals Inc
Common Stock, par value $0.0001 per share · CUSIP: 50180M108
Event date: 2025-09-12
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TCG Crossover GP II, LLC
Shares: 1,745,015 · Class: 7.8%
- TCG Crossover Fund II, L.P.
Shares: 1,745,015 · Class: 7.8%
- Chen Yu
Shares: 1,745,015 · Class: 7.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-207440
- Form type
- SCHEDULE 13G
- Filer
- LB PHARMACEUTICALS INC
- CIK
- CIK 1691082
- Filed
- Sep 18, 2025
- Reporting period
- Sep 12, 2025
- Description
- Schedule 13G beneficial ownership